Skip to main content

Table 1 Study characteristics

From: Craniosacral therapy for chronic pain: a systematic review and meta-analysis of randomized controlled trials

Reference

Origin

Chronic pain condition

Sample size

Mean age

Percentage of women

Experimental intervention

Control intervention

Assessment points

Outcomes

Safety

Funding

Arnadottir 2013 [36]

Iceland

Migraine

20

37.6 ± 9.3

90%

6 CST treatments (semi-standardized therapy protocol) over 4 weeks

WL

Post

- Functional disability (HIT-6)

N.r.

N.r.

Bialoszewski 2014 [37]

Poland

Low back pain

55

33.0 ± 7.0

N.r.

3 CST treatments (standardized therapy protocol) over 2 weeks

3 trigger point treatments over 2 weeks

Post

- Pain intensity (LPIQ)

N.r.

N.r.

- Functional disability (LPIQ)

Castro-Sanchez 2011 [38]

Spain

Fibromyalgia

109

52.5 ± 11.7

100%

40 CST treatments (semi-standardized therapy protocol) over 20 weeks

40 non-manual sham treatments (inactive magnet therapy) over 20 weeks

Post 7mFU

- Global improvement (CGII)

No withdrawal due to AEs

No specific funding

Castro-Sanchez 2016 [39]

Spain

Low back pain

64

50.0 ± 12.0

66%

10 CST treatments (semi-standardized therapy protocol) over 10 weeks

10 soft tissue massage treatments over 10 weeks

Post 3.5mFU

- Pain intensity (NRS)

No withdrawal due to AEs

No specific funding

- Functional disability (RMQ)

Elden 2013 [40]

Sweden

Pelvic girdle pain

123

30.6 ± 3.9

100%

5 CST treatments (semi-standardized therapy protocol) over 8 weeks + TAU

TAU

Post

- Pain intensity (VAS)

Patients with minor AEs: CST = 5/63 UC = 6/60

Government research grant

- Functional disability (ODI)

- Physical quality of life (EQ. 5D)

Haller 2016 [41]

Germany

Neck pain

54

44.6 ± 10.0

81.5%

8 CST treatments (semi-standardized therapy protocol) over 8 weeks

8 sham manual treatments (light touch) over 8 weeks

Post 5mFU

- Pain intensity (VAS)

Patients with minor AEs: CST = 7/27 Sham = 9/27

Funding from university (treatments) and CST associations (publication fee)

- Functional disability (NDI)

- Physical quality of life (SF12-PSC)

- Mental quality of life (SF12-MSC)

- Global improvement (PGII)

Hanten 1999 [42]

United States

Tension-type headache

60

36.0 ± 12.0

71.7%

1 CST treatment (single technique)

No treatment

Post

- Pain intensity (VAS)

N.r.

N.r.

Mann 2012 [35]

United States

Migraine

69

42.1 ± 16.0

94.2%

8 CST treatments (semi-standardized therapy protocol) over 8 weeks + TAU

8 non-manual sham treatments (inactive/active magnet therapy) over 8 weeks + TAU

Post

- Pain intensity (Diary: severe headache hours/day)

N.r.

Government research grant

- Functional disability (MIDAS)

Mataran-Penarrocha 2011 [43]

Spain

Fibromyalgia

104

49.1 ± 14.1

96.4%

50 CST treatments (semi-standardized therapy protocol) over 25 weeks

50 non-manual sham treatments (disconnected ultrasound) over 25 weeks

Post 11mFU

- Pain intensity (SF36-BP)

Patients with AEs: CST = 0/43 Sham = 0/41

N.r.

- Functional disability (SF36-PF)

- Physical quality of life (SF36-GH)

- Mental quality of life (SF36-MH)

Nourbakhsh 2008 [44]

United States

Lateral Epicondylitis

23

52.4 ± 7.2

39.1%

6 CST treatments (single technique) over 3 weeks

6 manual sham treatments (light touch) over 3 weeks

Post

- Pain intensity (NRS)

N.r.

N.r.

- Functional disability (PSFS)

  1. Abbreviations: AE Adverse event, CGII Clinical Global Impression of Improvement Scale CST Craniosacral Therapy, EQ. 5D European Quality of Life Measure, HIT-6 Headache Impact Test, LPIQ Laitinen Pain Indicator Questionnaire, mFU months of follow-up after randomization, MIDAS Migraine Disability Assessment Score, NDI Neck Disability Index, N.r.: not reported, NRS Numeric Rating Scale, ODI Oswestry Disability Index, PGII Patient Global Impression of Improvement Scale, PSFS Patient Specific Functional Scale, RMQ Roland Morris Disability Questionnaire, SF12/36-PCS/MCS/BP/GH/MH/PF: 12/36-Item Short Form Health Survey-Physical Component Score/Mental Component Score/Bodily Pain Subscale/Mental Health Subscale/General Health Subscale/Physical Function Subscale, TAU Treatment as usual, VAS Visual Analogue Scale, WL Waiting list